David Back
- Virology top 0.05%
- HIV Research and Treatment 157
- Infectious Diseases top 0.05%
- HIV/AIDS drug development and treatment 244
- HIV/AIDS Research and Interventions 64
- Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism 50
- Emergency Medicine top 0.2%
- HIV-related health complications and treatments 52
- Hepatology top 0.5%
- Hepatitis C virus research 41
-
- Pharmacological Effects and Toxicity Studies 70
-
- Drug Transport and Resistance Mechanisms 62
David Back
361 papers receiving 12.9k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Virology 4.7k
- Infectious Diseases 8.0k
- Pharmacology 2.1k
- Emergency Medicine 1.8k
- Hepatology 1.1k
Countries citing papers authored by David Back
This map shows the geographic impact of David Back's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Back with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Back more than expected).
Fields of papers citing papers by David Back
This network shows the impact of papers produced by David Back. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Back. The network helps show where David Back may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Back, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2019 | 8 | |
| 3 | 2017 | 4 | |
| 4 | 2014 | 5 | |
| 5 | 2011 | 7 | |
| 6 | 2011 | 28 | |
| 7 | 2011 | 82 | |
| 8 | 2010 | 20 | |
| 9 | 2009 | 194 | |
| 10 | 2008 | 11 | |
| 11 | 2006 | 11 | |
| 12 | 2003 | 141 | |
| 13 | 2002 | 26 | |
| 14 | 2001 | 36 | |
| 15 | 1997 | 159 | |
| 16 | Pharmacokinetics. Regulatory—Industrial—Academic Perspectives | 1995 | 1 |
| 17 | 1994 | 10 | |
| 18 | 1993 | 18 | |
| 19 | 1987 | 43 | |
| 20 | 1975 | 17 |
About David Back
David Back is a scholar working on Virology, Infectious Diseases and Pharmacology, having authored 364 papers that have together received 13.4k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (244 papers), HIV Research and Treatment (157 papers), Pharmacological Effects and Toxicity Studies (70 papers), HIV/AIDS Research and Interventions (64 papers), Drug Transport and Resistance Mechanisms (62 papers), HIV-related health complications and treatments (52 papers), Pharmacogenetics and Drug Metabolism (50 papers) and Hepatitis C virus research (41 papers). The work is most often cited by research in Virology (4.7k citations), Infectious Diseases (8.0k citations) and Pharmacology (2.1k citations). David Back has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include Saye Khoo, Michael Barry, Andrew Owen, Sara Gibbons, Michael Orme, John Tjia, Patrick G. Hoggard, Marta Boffito, Catia Marzolini and Fiona Mulcahy. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Antiviral Therapy, AIDS, Antimicrobial Agents and Chemotherapy and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.